CN Patent

CN107854446A — 一种盐酸鲁拉西酮口崩片及其制备方法

Assigned to Foshan Hongtai Pharmaceutical Development Co Ltd · Expires 2018-03-30 · 8y expired

What this patent protects

本发明公开了一种盐酸鲁拉西酮口崩片及其制备方法。所述口崩片是一种包含盐酸鲁拉西酮、填充剂、崩解剂、润湿剂与粘合剂、矫味剂、润滑剂的药物组合物，所述制备方法采用湿法制粒压片法。本发明的目的是提供一种制备工艺简单、成本低廉、服用方便、起效迅速、生物利用度高的盐酸鲁拉西酮口崩片，该剂型能提高患者的服药顺应性。

USPTO Abstract

本发明公开了一种盐酸鲁拉西酮口崩片及其制备方法。所述口崩片是一种包含盐酸鲁拉西酮、填充剂、崩解剂、润湿剂与粘合剂、矫味剂、润滑剂的药物组合物，所述制备方法采用湿法制粒压片法。本发明的目的是提供一种制备工艺简单、成本低廉、服用方便、起效迅速、生物利用度高的盐酸鲁拉西酮口崩片，该剂型能提高患者的服药顺应性。

Drugs covered by this patent

lurasidone-hydrochloride (LURASIDONE HYDROCHLORIDE)

Patent Metadata

Patent number: CN107854446A
Jurisdiction: CN
Classification: —
Expires: 2018-03-30
Drug substance claim: No
Drug product claim: No
Assignee: Foshan Hongtai Pharmaceutical Development Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.